1. Central Insulin Action Activates Kupffer Cells by Suppressing Hepatic Vagal Activation via the Nicotinic Alpha 7 Acetylcholine Receptor.
- Author
-
Kimura, Kumi, Tanida, Mamoru, Nagata, Naoto, Inaba, Yuka, Watanabe, Hitoshi, Nagashimada, Mayumi, Ota, Tsuguhito, Asahara, Shun-ichiro, Kido, Yoshiaki, Matsumoto, Michihiro, Toshinai, Koji, Nakazato, Masamitsu, Shibamoto, Toshishige, Kaneko, Shuichi, Kasuga, Masato, and Inoue, Hiroshi
- Abstract
Summary Central insulin action activates hepatic IL-6/STAT3 signaling, which suppresses the gene expression of hepatic gluconeogenic enzymes. The vagus nerve plays an important role in this centrally mediated hepatic response; however, the precise mechanism underlying this brain-liver interaction is unclear. Here, we present our findings that the vagus nerve suppresses hepatic IL-6/STAT3 signaling via α7-nicotinic acetylcholine receptors (α7-nAchR) on Kupffer cells, and that central insulin action activates hepatic IL-6/STAT3 signaling by suppressing vagal activity. Indeed, central insulin-mediated hepatic IL-6/STAT3 activation and gluconeogenic gene suppression were impeded in mice with hepatic vagotomy, pharmacological cholinergic blockade, or α7-nAchR deficiency. In high-fat diet-induced obese and insulin-resistant mice, control of the vagus nerve by central insulin action was disturbed, inducing a persistent increase of inflammatory cytokines. These findings suggest that dysregulation of the α7-nAchR-mediated control of Kupffer cells by central insulin action may affect the pathogenesis of chronic hepatic inflammation in obesity. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF